AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. > Summary
Court Case Number 1:15-cv-00999
Filing Date Oct 30, 2015
Court Delaware District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
7AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Jill Kirsten Macalpine
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Ryan P. O'Quinn
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
Attorney Name: Charles E. Lipsey
Defendant Attorneys
6Viatris Inc.
Attorney Name: David A. Bilson
Viatris Inc.
Attorney Name: Gregory J. Brodzik
Young Conaway Stargatt & Taylor
Viatris Inc.
Attorney Name: James M. Lennon
Young Conaway Stargatt & Taylor
Viatris Inc.
Attorney Name: Mark A. Pacella
Wiley Rein LLP
Viatris Inc.
Attorney Name: James H. Wallace Jr.
Wiley Rein LLP
Viatris Inc.
Attorney Name: Wesley E. Weeks
Wiley Rein LLP
Counter Defendant
4Counter Claimant
7Viatris Inc.
Attorney Name: David A. Bilson
Viatris Inc.
Attorney Name: Gregory J. Brodzik
Young Conaway Stargatt & Taylor
Viatris Inc.
Attorney Name: James M. Lennon
Young Conaway Stargatt & Taylor
Viatris Inc.
Attorney Name: Mark A. Pacella
Wiley Rein LLP
Viatris Inc.
Attorney Name: John C. Phillips Jr.
Viatris Inc.
Attorney Name: James H. Wallace Jr.
Wiley Rein LLP
Viatris Inc.
Attorney Name: Wesley E. Weeks
Wiley Rein LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08425934 | Pharmaceutical compositions | Apr 23, 2013 |
| 07265124 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound | Sep 4, 2007 |
| 07250419 | Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition | Jul 31, 2007 |
| 06525060 | Triazolo(4,5-d)pyrimidine compounds | Feb 25, 2003 |
| 06251910 | 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists | Jun 26, 2001 |
